Evidence map›Paper›PMID 31006839›Full record

ArticleArchives of gynecology and obstetrics2019

A GCIG international survey: clinical practice patterns of sentinel lymph node biopsies in cervical cancer.

G F Vercellino, E Erdemoglu, P Lichtenberg, M Z Muallem, R Richter, N R Abu-Rustum, M Plante, F Lécuru, S Greggi, B J Monk and 8 more

Open access · greenAbstract read
In one paragraph

Article in Archives of gynecology and obstetrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Change in practice in gynecologic oncology during the COVID-19 pandemic: a social media survey.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2020
    Article
  11. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 6 countries.

G F VercellinoDepartment of Gynecology With Center for Oncological Surgery, Charité Universtitätmedizin, Charité Platz 1, 10117, Berlin, Germany. enonloso1@hotmail.com.ORCID 0000-0002-2228-5495
E ErdemogluDepartment of Gynecologic Oncology, Suleyman Demirel University, Isparta, Turkey.
P LichtenbergDepartment of Gynecology With Center for Oncological Surgery, Charité Universtitätmedizin, Charité Platz 1, 10117, Berlin, Germany.
M Z MuallemDepartment of Gynecology With Center for Oncological Surgery, Charité Universtitätmedizin, Charité Platz 1, 10117, Berlin, Germany.
R RichterDepartment of Gynecology With Center for Oncological Surgery, Charité Universtitätmedizin, Charité Platz 1, 10117, Berlin, Germany.
N R Abu-RustumGynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
M PlanteDivision of Gynecologic Oncology, Centre Hospitalier Universitaire de Laval Québec, Quebec, Canada.
F LécuruDepartment of Gynecologic Oncologic and Breast Surgery, Hôpital Européen Georges Pompidou (HEGP), Paris, France.
S GreggiGynecologic Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori di Napoli, Naples, Italy.
B J MonkUniversity of Arizona Cancer Center-Phoenix, Creighton University School of Medicine at St Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
S SagaeDepartment of Gynecologic Oncology, Sapporo West Kojinkai Clinic, Sapporo, Japan.
C DenkertDepartment of Pathology, Charité Universtitätmedizin, Berlin, Germany.
M KellerDepartment of Gynecology With Center for Oncological Surgery, Charité Universtitätmedizin, Charité Platz 1, 10117, Berlin, Germany.
M AlhakeemDepartment of Gynecology With Center for Oncological Surgery, Charité Universtitätmedizin, Charité Platz 1, 10117, Berlin, Germany.
M HellriegelClinic for Obstetrics and Gynecology, UMG Universitätmedizin, Göttingen, Germany.
A M DückelmannDepartment of Gynecology With Center for Oncological Surgery, Charité Universtitätmedizin, Charité Platz 1, 10117, Berlin, Germany.
V ChianteraDepartment of Gynecologic Oncology, University of Palermo, Palermo, Italy.
Jalid SehouliDepartment of Gynecology With Center for Oncological Surgery, Charité Universtitätmedizin, Charité Platz 1, 10117, Berlin, Germany. Jalid.sehouli@charite.de.
Charité - Universitätsmedizin Berlin · DEUniversitätsmedizin Göttingen · DECreighton University · USDélégation Paris 5 · FRKing Saud University · SAMemorial Sloan Kettering Cancer Center · USSüleyman Demirel University · TRUniversity of Palermo · IT

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

purposeTo evaluate the practice patterns among centers and physicians worldwide regarding sentinel lymph node biopsies (SLNB) in cervical cancer (CC) patients.

methodA validated 35-item questionnaire regarding SLNB in CC supported by the Gynecologic Cancer Intergroup (GCIG), and sponsored by the North-Eastern German Society of Gynaecologic-Oncology (NOGGO) was sent to all major gynecological cancer societies across the globe for further distribution from October 2015 and continued for a period of 7 months.

resultsOne hundred and sixty-one institutions from around the world participated. One hundred and six (66%) of the participants were from university centers and 111 (69%) were gynecologic oncologists. One hundred and fifty-two (97%) performed lymphadenectomy (LNE) and 147 (94%) did so systematically; 97 (60%) used SLNB, due to lower morbidity (73%), reliability (55%) and time-saving (27%). In cases of positive SLNB (pN+), 39% of respondents stopped the operation and sent the patient for chemoradiation (CRT), 45% completed pelvic and paraaortic LNE, whereas 26% went on to perform a radical hysterectomy (RH) and systematic pelvic and paraaortic LNE. In case of negative SLNB (pN0), 39% of institutions still performed a systematic pelvic and paraaortic LNE.

conclusionIn this survey worldwide, SLNB adoption is an encouraging 60%, yet ample differences exist regarding strategy, and to a lower extent the techniques used. Lack of experience is the most common reason SLNB is not performed. Efforts to increase surgical education on SLNB technique and multicenter prospective trials providing evidence-based guidelines are warranted.

Indexed as

FemaleHumansMiddle AgedProspective StudiesSentinel Lymph Node BiopsySurveys and QuestionnairesUterine Cervical NeoplasmsCervical cancerInternational surveySentinel lymph node biopsy

Identifiers

PMID31006839
PMCPMC7469255
OpenAlexW2938466474

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.